Global Influenza Vaccines Market to Grow at Double Digit CAGR During 2013-2019

Share Article

Market Research now carries a research report titled, “Influenza Vaccines Market & Forecast - Worldwide Analysis” that delivers a comprehensive analysis of the global influenza vaccines market.

The seasonal influenza vaccines market is projected to demonstrate a healthy growth rate with a double-digit percentage during the forecast period of 2013 to 2019.

View Full Report at

The report further states that the influenza vaccines market represents an attractive market which is characterized by its sturdy growth potential. The key drivers for this market include: growing health awareness, increasing vaccination coverage (particularly in the emerging nations), accelerating support from government for immunization against seasonal influenza, and improved focus on the production of treatments for vulnerable populations with introduction of new vaccines and vaccines which offer a better route of administration.

The market of H1N1 influenza vaccines witnessed record-high growth during 2009-2010. According to CDC, on April 12, 2009 approximately 60.8 million cases occurred in the United States alone due to H1N1. The global spread of H1N1 virus was the primary driver for the growth of the H1N1 influenza vaccines industry during 2009-2010.

Download Detail Report With Complete TOC at

The report provides a detailed evaluation of regional seasonal influenza vaccines market according to countries. Many developing and emerging countries seasonal influenza vaccines market and vaccination coverage is included in the report. Some of the countries mentioned in this research report are United States, Japan, China, India, Brazil, Netherlands, Germany, France, Italy, Spain, Denmark, Sweden, Portugal, United Kingdom, Poland, etc.

Currently, United States is the largest country-wise market segment for seasonal influenza vaccines. Japan with emerging nations such as India, Brazil, and China is likely to fuel the growth of the global influenza vaccines market during the forecast period. On the other hand, United Kingdom and Netherlands will demonstrate a greater vaccination coverage in the coming few years. The global seasonal influenza vaccine market by brand is divided into Afluria/Fluvax, Fluarix/Flulaval, FluMist/Fluenz, Influvac (Now Acquired by Abbott), Fluvirin/Flucelvax, and Fluzone. Currently, Fluzone (Sanofi Pasteur) has the highest sales figures and will continue its dominance in the coming few years in the seasonal influenza vaccines market. A detailed sales performance analysis with forecast for each brand is mentioned in the report.

Explore All Vaccines Market Research Reports at

Apart from the above key drivers, many other factors support the growth of the influenza vaccines market. Factors such as transforming vaccine technologies, affordability of vaccines against disease prevention, and scientific and technological breakthroughs are also contributing to the growth of the global influenza vaccines market. Furthermore, increasing awareness from education, training, and information exchange on seasonal influenza contributes to the growth of the influenza vaccines market. Even though, the global influenza vaccines market will demonstrate a healthy double digit growth rate, economic, technical, cultural aspects tend to create an obstacle for the best possible use of licensed vaccines. Moreover, general technical barriers, economic barriers, legal barriers, and regulatory barriers tend to pose difficulty for influenza vaccine development and approval. Other two key issues that restrain the growth of the influenza vaccine market are reducing timeline for vaccine development and problem faced by healthcare providers in immunization.

About is the most comprehensive collection of market research reports, supporting clients’ market intelligence needs with over 100,000 market research reports, company profiles, data books, and regional market profits in its repository. We also offer consulting support for custom market research needs.

Our document database is updated by the hour, which means that our customers always have access to fresh data spanning over 300 industries. From Fortune 500 companies to SMEs, has built a veritable reputation for fulfilling the most exacting market research needs.


Sheela AK
State Tower
90 State Street,
Suite 700, Albany
NY 12207, United States
Toll Free: 866-997-4948

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michell Thoras

Sheela AK
Follow us on
Visit website